Filing Date Form TypeDescription   
   
Data pager
 Page 1 of 5, items 1 to 13 of 65.
2022-05-168-KCurrent report, item 8.01 Acc-no: 0001753926-22-000715 (34 Act)  Size: 192 KB
2022-05-118-KCurrent report, items 7.01 and 9.01 Acc-no: 0001753926-22-000688 (34 Act)  Size: 241 KB
2022-04-018-KCurrent report, item 1.01 Acc-no: 0001753926-22-000404 (34 Act)  Size: 198 KB
2022-03-168-KCurrent report, item 8.01 Acc-no: 0001753926-22-000313 (34 Act)  Size: 187 KB
2022-03-148-KCurrent report, item 2.01 Acc-no: 0001753926-22-000311 (34 Act)  Size: 189 KB
2022-02-238-KCurrent report, item 1.01 Acc-no: 0001753926-22-000230 (34 Act)  Size: 199 KB
2022-02-178-KCurrent report, items 1.01 and 8.01 Acc-no: 0001753926-22-000216 (34 Act)  Size: 199 KB
2022-02-038-KCurrent report, item 8.01 Acc-no: 0001753926-22-000128 (34 Act)  Size: 192 KB
2022-01-118-KCurrent report, item 8.01 Acc-no: 0001753926-22-000044 (34 Act)  Size: 191 KB
2022-01-038-KCurrent report, item 8.01 Acc-no: 0001753926-22-000007 (34 Act)  Size: 186 KB
2021-11-238-KCurrent report, item 8.01 Acc-no: 0001753926-21-000734 (34 Act)  Size: 187 KB
2021-11-108-KCurrent report, item 8.01 Acc-no: 0001753926-21-000668 (34 Act)  Size: 196 KB
2021-10-228-KCurrent report, item 8.01 Acc-no: 0001753926-21-000574 (34 Act)  Size: 21 KB


RedHawk Reports 3rd Quarter Results
05/24/2021 8:15 PM

RedHawk Holdings Corp. (OTC: SNDD) ("RedHawk" or the "Company"), a diversified holding company engaged primarily in sales and distribution of medical devices, reported today a net loss from operations of $425,479 for the nine month period ended March 31, 2021 on gross revenues of $867,841. Net of distributor and introductory discounts of $177,095, net revenues for the nine month period ended March 31, 2021 were $690,746. For the trailing twelve month period ended March 31, 2021, RedHawk reported a net loss from operations of $211,986 on gross revenues of $1,831,297, and net revenues of $1,606,035.

Pharming celebrates the 10th annual "hae day :-)"
05/17/2021 5:00 AM

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) supports the 10th annual "hae-day :-)", the global awareness day for hereditary angioedema (HAE), a rare life-threatening condition.